Anthony Gentile
Corporate Officer/Principal en BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. .
Origen de la red de primer grado Anthony Gentile.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 50 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony Gentile a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Compliance Officer Director/Board Member Corporate Secretary Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Human Resources Officer Chief Tech/Sci/R&D Officer General Counsel Comptroller/Controller/Auditor Director of Finance/CFO Investor Relations Contact | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Miscellaneous Commercial Services | Director of Finance/CFO Chairman Chief Operating Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PORTAGE BIOTECH INC. | Biotechnology | Director of Finance/CFO Founder Chief Executive Officer | |
| Our Lady of Mercy Academy | Director/Board Member Director/Board Member | ||
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kleo Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of biospecific compounds designed to emulate and enhance the activity of biologics. Its compounds are designed to direct the immune system to destroy cancerous or virally infected cells, and treatment of multiple myeloma and COVID-19. It offers Antibody Recruiting Molecules (ARMs),Synthetic Antibody Mimics (SyAMs), and Monoclonal Antibody Therapy Enhancers (MATEs) pipeline. The company was founded by David A. Spiegel and Roy Prieb in 2015 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AKILI, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Undergraduate Degree | |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder Founder | |
Pyramid Biosciences, Inc.
 Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| Georgetown University | College/University | Graduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Director of Finance/CFO Chief Executive Officer | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Founder Founder | |
iOX Therapeutics Ltd.
 iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director of Finance/CFO Chairman | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Undergraduate Degree | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SALVARX GROUP PLC | Biotechnology | Director of Finance/CFO Founder | |
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Founder Corporate Officer/Principal | |
| Harvard T.H. Chan School of Public Health | College/University | Corporate Officer/Principal Doctorate Degree | |
PRISM Technologies LLC
 PRISM Technologies LLC Miscellaneous Commercial ServicesCommercial Services Part of Sabre Corp., PRISM Technologies LLC is a company that provides intellectual property licensing, and technology research and development services. The company is based in Omaha, NE. The company was founded by Gregory J. Duman. PRISM Technologies was acquired by Prism Technologies Group, Inc. on March 30, 2015 for $75.15 million. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Corporate Officer/Principal | |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer Japan, Inc. is a research and Japanese development pharmaceutical company founded in 1953. The company is based in Tokyo, Japan. The company's focus is on breakthroughs that greatly change patients' lives, contributing to the improvement of patients' health and life expectancy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Glasgow | College/University | Doctorate Degree | |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Causeway Therapeutics Ltd.
 Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | Pharmaceuticals: Major | Chairman | |
| INTENSITY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
| Kitasato University | College/University | Corporate Officer/Principal | |
| University of Glasgow School of Medicine | College/University | Corporate Officer/Principal | |
| University of Kent | College/University | Doctorate Degree | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
BYOMass, Inc.
 BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services BYOMass, Inc. provides investment holding services. The company is headquartered in Sudbury, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Apterna Ltd. | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 27 |
| Reino Unido | 15 |
| Japón | 4 |
| Irlanda | 3 |
| Canadá | 2 |
Sectorial
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 8 |
| Finance | 5 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 204 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 55 |
| Chairman | 42 |
| Undergraduate Degree | 33 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| John Childs | 40 |
| Gregory Bailey | 36 |
| Albert Cha | 30 |
| Eric Aguiar | 29 |
| Declan Doogan | 28 |
| Robert Hugin | 24 |
| Michael Heffernan | 23 |
| Julia Gregory | 22 |
| Irina Antonijevic | 17 |
| Kishan Mehta | 15 |
| William Jones | 14 |
| Vladimir Coric | 14 |
| Matthew Buten | 13 |
| St John McGrath | 10 |
| Kamlesh Shah | 10 |
- Bolsa de valores
- Insiders
- Anthony Gentile
- Conexiones Empresas
